Clinical Trials Browser

Phase 2 × Thrombocythemia, Essential × lestaurtinib × Clear all

NCT00586651 2015-10-08

Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis

Phase 2 Completed

Polycythemia Vera, Thrombocythemia, Essential